SCHEMBL8204424

SCHEMBL8204424

Cl[Si](Cl)(Cl)CC(c1ccccc1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 6/20 0.46
TAAR1 Q96RJ0 1/20 0.46
TSHR P16473 1/20 0.43
HRH1 P35367 6/20 0.42
SLC6A3 Q01959 3/20 0.40
SLC6A2 P23975 2/20 0.40
SLC6A4 P31645 2/20 0.40
TDP1 Q9NUW8 1/20 0.39
CHRNB2 P17787 1/20 0.38
CHRNA4 P43681 1/20 0.38
DPP4 P27487 2/20 0.38
F2 P00734 1/20 0.38
CACNA1F O60840 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
ADRA2B P18089 1/20 0.38
CHRM3 P20309 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRK1 P41145 1/20 0.38
CACNA1D Q01668 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18662207 0.80 HRH1 (0.43) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL18662236 0.80 HRH1 (0.43) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL1504701 0.80 TSHR (0.46) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL6845944 0.78 TSHR (0.39) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL5413664 0.78 TAAR1 (0.52) TAAR1TSHR
SCHEMBL18662201 0.78 HTR2A (0.41) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL18662240 0.78 HTR2A (0.41) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL2101611 0.77 TSHR (0.37) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL18662209 0.77 HRH1 (0.40) HTR2ATAAR1TSHRHRH1SLC6A3
SCHEMBL18662194 0.77 HRH1 (0.40) HTR2ATAAR1TSHRHRH1SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6022987-A Aryl substituted alkylsilanes and a preparation method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-02-08 US claimed
US-9862735-B2 Organosilicon compound having diphenylethyl and methoxysilyl and making method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2018-01-09 US disclosed
US-20170088568-A1 ORGANOSILICON COMPOUND HAVING DIPHENYLETHYL AND METHOXYSILYL AND MAKING METHOD SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-03-30 US disclosed
US-6022987-A Aryl substituted alkylsilanes and a preparation method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2000-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088568-A1 ORGANOSILICON COMPOUND HAVING DIPHENYLETHYL AND METHOXYSILYL AND MAKING METHOD MSN, SI, HDHD5 HTR2A 2796/4885TAAR1 4505/4885TSHR 4488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.